{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-099393","form_type":"8-K","ticker":"OSRH","cik":"0001840425","company_name":"OSR Holdings, Inc.","filed_at":"2025-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.745720+00:00","generated_at":"2026-05-17T03:35:33.779855+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"OSRH acquires WORIO for $10.6M in stock; non-invasive glucose monitoring tech","bullets":["OSRH subsidiary OSRK to acquire WORIO via share exchange for KRW 15B (~USD 10.6M). WORIO becomes indirect wholly owned subsidiary.","WORIO develops needle-free continuous glucose monitor using NIRS technology; has an active partnership with Samsung for clinical trials with non-dilutive funding.","Each WORIO share exchanged for 0.948832 OSRK shares; OSRK issues 84,338 new shares for 88,891 WORIO shares.","If OSRH stock reaches $10 within 3 years, OSRK shares may convert into OSRH common at 12.96:1 ratio, up to ~1.09M new shares.","Closing expected Jan 12, 2026, subject to WORIO shareholder vote (Dec 19, 2025) and regulatory clearances."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-099393","json":"https://secwatch.observer/filing/0001213900-25-099393.json","markdown":"https://secwatch.observer/filing/0001213900-25-099393.md","text":"https://secwatch.observer/filing/0001213900-25-099393.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840425/000121390025099393/0001213900-25-099393-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840425/000121390025099393/ea0261472-8k_osrhold.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:35:33.779855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}